{"protocolSection":{"identificationModule":{"nctId":"NCT05529901","orgStudyIdInfo":{"id":"JPS 21-08"},"organization":{"fullName":"W.L.Gore & Associates","class":"INDUSTRY"},"briefTitle":"Japan Post Marketing Surveillance of the GORE速 CARDIOFORM Septal Occluder","officialTitle":"Post Marketing Surveillance of the GORE速 CARDIOFORM Septal Occluder","acronym":"GSO-PFO PMS"},"statusModule":{"statusVerifiedDate":"2023-07","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-10-03","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-09","type":"ESTIMATED"},"completionDateStruct":{"date":"2031-05","type":"ESTIMATED"},"studyFirstSubmitDate":"2022-08-23","studyFirstSubmitQcDate":"2022-09-02","studyFirstPostDateStruct":{"date":"2022-09-07","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-07-11","lastUpdatePostDateStruct":{"date":"2023-07-12","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"W.L.Gore & Associates","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUsExport":true},"descriptionModule":{"briefSummary":"The purpose of this post-marketing surveillance is to evaluate the effectiveness and safety of GORE速 CARDIOFORM Septal Occluder under the post-marketing setting in Japan."},"conditionsModule":{"conditions":["Stroke","PFO - Patent Foramen Ovale","Cryptogenic Stroke","TIA"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"CASE_ONLY","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":300,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DEVICE","name":"GORE速 CARDIOFORM Septal Occluder","description":"Patients for whom the device is used (implanted or used by not implanted) during the enrollment period of this post-marketing surveillance will be considered eligible for the study"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"PFO Closure Rate","description":"PFO closure success will be defined as the number of cases which achieve effective PFO closure at 12 months post-initial procedure out of those which complete the PFO closure evaluation under Trans-Thoracic Echocardiography (TTE) with bubbles. PFO effective closure will be defined as the number of bubbles confirmed to be less than 20 (\\<20).","timeFrame":"12 months"},{"measure":"Rate of Conversion to surgical procedure","description":"Rate of post-procedure conversion to surgical procedure will be calculated.","timeFrame":"Discharge"},{"measure":"Incidence rate of post-procedure ischemic stroke events","description":"Incidence rate of post-procedure ischemic stroke will be calculated. Additionally, those stroke events will be evaluated by Kapan-Meier plot.","timeFrame":"36 months"},{"measure":"Device success","description":"Device success will be calculated by the number of cases with successful device implant during the initial procedure and later follow-ups out of those which underwent the transcatheter PFO closure procedure.","timeFrame":"36 months"},{"measure":"Incidence rate of post-procedure adverse events and/or device issues","description":"Incidence rate of adverse events and/or device issues collected through each follow-up period will be calculated.","timeFrame":"36 months"},{"measure":"Incidence rate of device- and procedure-related events within 30 days post procedure","description":"Incidence rate of adverse events and/or device issues which are defined as device- or procedure-related within 30 days post procedure will be calculated.","timeFrame":"30 days"}],"otherOutcomes":[{"measure":"Incidence rate of post-procedure Atrial fibrillation","description":"Rate of post-procedure AF will be calculated during each follow-up period.","timeFrame":"36 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosed with cryptogenic stroke (including transient ischemic attack with positive head imaging findings)\n* Diagnosed with a PFO\n* Note: Additional Inclusion Criteria may apply\n\nExclusion Criteria:\n\n* N/A","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients who have had a cryptogenic stroke (including transient ischemic attack with positive head imaging findings) with possible involvement of patent foramen ovale (PFO) due to a presumed paradoxical embolism.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Masaru Ohara","role":"CONTACT","phone":"81 70 1596 0480","email":"maohara@wlgore.com"},{"name":"Kazuma Minomiya","role":"CONTACT","email":"kminomiy@wlgore.com"}],"locations":[{"facility":"Okayama University Hospital","status":"RECRUITING","city":"Okayama","zip":"700-8558","country":"Japan","geoPoint":{"lat":34.65,"lon":133.93333}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000054092","term":"Foramen Ovale, Patent"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000006344","term":"Heart Septal Defects, Atrial"},{"id":"D000006343","term":"Heart Septal Defects"},{"id":"D000006330","term":"Heart Defects, Congenital"},{"id":"D000018376","term":"Cardiovascular Abnormalities"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000000013","term":"Congenital Abnormalities"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M27260","name":"Foramen Ovale, Patent","asFound":"Patent Foramen Ovale","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Cryptogenic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M9122","name":"Heart Septal Defects, Atrial","relevance":"LOW"},{"id":"M9121","name":"Heart Septal Defects","relevance":"LOW"},{"id":"M9108","name":"Heart Defects, Congenital","relevance":"LOW"},{"id":"M12","name":"Congenital Abnormalities","relevance":"LOW"},{"id":"M20193","name":"Cardiovascular Abnormalities","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}